RAC 1.75% $1.68 race oncology ltd

Ann: Impressive Preclinical Bisantrene Breast Cancer Results, page-106

  1. 2,683 Posts.
    lightbulb Created with Sketch. 10336
    Yes it is very strong - consistently seen in all the trials ( there have been over 40). This is not too surprising given Bisantrene was deliberately developed to be like the anthracyclines in action, but without the toxicity. Lederle spent a lot of time and money on developing Bisantrene.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.68
Change
-0.030(1.75%)
Mkt cap ! $286.2M
Open High Low Value Volume
$1.73 $1.73 $1.68 $119.9K 70.42K

Buyers (Bids)

No. Vol. Price($)
1 3012 $1.66
 

Sellers (Offers)

Price($) Vol. No.
$1.70 6382 1
View Market Depth
Last trade - 15.07pm 03/09/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.